Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Midazolam vs propofol vs dexmedetomidine for sedation during cataract surgery
IRCT20221020056250N1Phase 4Completed
- Sponsor
- Golestan University of Medical Sciences
- Start
- Dec 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, double-blind trial of midazolam, propofol and dexmedetomidine in cataract (3 arms), sponsored by Golestan University of Medical Sciences. Primary endpoints: Hemodynamic changes, Heart rate and 3 more. Started Dec 2022; status: completed.
02
Drugs
midazolampropofoldexmedetomidine
03
Conditions
cataract
Beyond the preview
Go deeper on IRCT20221020056250N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20221020056250N1.